| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research
1 company
Murphy Andrew J is an EVP Research at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 145 sells.
Estimated insider holdings value: $29.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 6,363 | $1,153.15 | $7,337,504.87 | -0.7% | -29.0% | -51.1% | |
| Mar 14, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 5,783 | $956.47 | $5,531,289.51 | -0.8% | +7.2% | -30.5% | |
| Dec 5, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 6,536 | $817.44 | $5,342,787.40 | -0.9% | +18.3% | -8.1% | |
| Nov 14, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 6,974 | $799.59 | $5,576,349.78 | -1.0% | +19.3% | +1.3% | |
| Nov 15, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 3,720 | $727.81 | $2,707,467.33 | -0.3% | +4.8% | +8.7% | |
| Aug 16, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 3,513 | $645.49 | $2,267,600.12 | -0.5% | +14.4% | +22.9% | |
| May 17, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 3,543 | $663.68 | $2,351,411.44 | -0.4% | -3.6% | +12.3% | |
| Feb 15, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 3,540 | $629.34 | $2,227,850.52 | -0.5% | +3.9% | +19.4% | |
| Dec 10, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 7,122 | $666.27 | $4,745,202.38 | -0.7% | -5.8% | +12.0% | |
| Nov 16, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research | Sale+OE | 7,167 | $647.17 | $4,638,262.83 | -0.7% | -3.0% | +14.5% |